Latest News and Press Releases
Want to stay updated on the latest news?
-
København og Oslo, 19 juli 2012, 2012-07-19 08:00 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler, at Trans Nova Investment Limited (Trans Nova),...
-
Copenhagen and Oslo, 19th July, 2012, 2012-07-19 08:00 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today Trans Nova Investment Limited (Trans...
-
København og Oslo, 17. juli 2012, 2012-07-17 10:15 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler i dag følgende: NASDAQ OMX Copenhagen har...
-
Copenhagen and Oslo, 17th July, 2012, 2012-07-17 10:15 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today the following: NASDAQ OMX...
-
Copenhagen, 17th July, 2012 On behalf of Trans Nova Investments Limited, a press release and an offer document is hereby made public regarding a new voluntary conditional public purchase...
-
København, d. 17. juli 2012 På vegne af Trans Nova Investments Limited offentliggøres herved pressemeddelelse og tilbudsdokument vedrørende nyt frivilligt betinget offentligt købstilbud til...
-
Copenhagen and Oslo, 6th July, 2012, 2012-07-06 14:20 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today NASDAQ OMX Copenhagen has responded...
-
København og Oslo, 6. juli 2012, 2012-07-06 14:20 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler i dag, at NASDAQ OMX Copenhagen har...
-
København og Oslo, 1. juli 2012, 2012-07-01 19:11 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler i dag, at International Biotech Center Generium...
-
Copenhagen and Oslo, 1st July, 2012, 2012-07-01 19:11 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today that International Biotech Center...